Search for: "Does 1 - 20" Results 2581 - 2600 of 28,799
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
23 Feb 2023, 1:00 am by Tian Lu
In the fight against intellectual property rights (IPRs) infringements, China does not consider punitive damages as a taboo. [read post]
22 Feb 2023, 1:21 pm by John Floyd
This can be increased to up to 20 years in prison or $1 million per count if an individual is found guilty of intentionally falsifying material facts. [read post]
22 Feb 2023, 1:07 pm by Dennis Crouch
  Stroud is General Counsel at Unified Patents – an organization often adverse to litigation-funded entities.[1] He is also an adjunct professor at American University Washington College of Law. [read post]
21 Feb 2023, 8:44 am by Eugene Volokh
" The Act exempts contracts if a company provides goods or services for at least 20% less than the lowest certifying business, or if the contract has a total potential value of less than $1,000. [read post]
21 Feb 2023, 6:41 am by Andy Wright
Cannon, Chairman, Senate Comm. on Rules and Administration, at 6 (Sept. 20, 1974) (“Certainly the Vice President is not a Member of Congress as that term is used in the Constitution. [read post]
21 Feb 2023, 3:30 am by Kevin Kaufman
For example, the top rate kicks in at or above $1 million in California (when the “millionaire’s tax” surcharge is included), Massachusetts, New Jersey, New York, and the District of Columbia. [read post]
20 Feb 2023, 8:48 am by Allison Benoit and Gregory Anding
Union Carbide Corporation, 20-252 (La.App. 4 Cir. 04/01/2021), 2021 WL 1227137, as clarified on reh’g, 20-252 (La.App. 4 Cir. 05/12/2021), 2021 WL 1917784. [read post]
20 Feb 2023, 4:30 am by Michael C. Dorf
DorfToday is Presidents' Day--or, as we say here at Cornell Law School, Monday February 20, which we treat as no different from any other typical Monday during the academic year. [read post]
20 Feb 2023, 4:23 am by Matthieu Dhenne (Ipsilon)
According to the Supreme Court, it follows from the above-mentioned case law of the CJEU that “when the marketing authorization does not qualify a substance as an “active principle”, it is rebuttably presumed that this substance does not produce its own pharmacological, immunological or metabolic effect covered by the therapeutic indications referred to in that marketing authorization”. [read post]
19 Feb 2023, 9:05 pm by Reeve T. Bull
Key questions in this analysis include: What social benefits does a regulation create? [read post]